Immunomodulatory properties of increased levels of liver X receptor β in peripheral blood mononuclear cells from multiple sclerosis patients

Experimental Neurology

Volumn 204, Issue 2, 2007, Pages 759-766

  Giorelli, Maurizio ^a,b,c   Livrea, Paolo ^a   Minervini, Mauro Giuseppe ^b   Trojano, Maria ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UO of Neurology ^*  (Italy)

^c Laboratory of Neurogenetics and Experimental Neurobiology   (Italy)

Author keywords

ABCA1; Cholesterol; HMGCoA reductase; IFN ; IL 4; LXR ; Lymphocytes; Multiple sclerosis

Indexed keywords

ABC TRANSPORTER A1; BETA ACTIN; CHOLESTEROL; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 4 ANTIBODY; LIVER X RECEPTOR BETA; MESSENGER RNA;

ADULT; ARTICLE; CELL VIABILITY; CENTRAL NERVOUS SYSTEM DISEASE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIGENS, CD; ATP-BINDING CASSETTE TRANSPORTERS; CELL PROLIFERATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INTERFERON TYPE II; LEUKOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; SULFONAMIDES; T-LYMPHOCYTES;

EID: 34047190250     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.01.013     Document Type: Article

References (24)

1. Aktas O., Waiczies S., Smorodchenko A., Dorr J., Seeger B., Prozorovski T., Sallach S., Endres M., Brocke S., Nitsch R., and Zipp F. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197 6 (2003) 725-733
2. Andersson S., Gustafsson N., Warner M., and Gustafsson J. Inactivation of liver X receptor β leads to adult-onset motor neuron degeneration in male mice. PNAS 102 10 (2005) 3857-3862
3. Brousseau Me. ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption. Curr. Opin. Lipidol. 14 1 (2003) 35-40
4. Brown J., Theisler C., Silberman S., Magnuson D., Gottardi-Littel N., Lee J.M., Yager D., Crowley J., Sambamurti K., Rahman M.M., Reiss A.B., Eckman C.B., and Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279 33 (2004) 34674-34681
5. Castrillo A., Joseph S.B., Marathe C., Mangelsdorf D.J., and Tontonoz P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278 12 (2003) 10443-10449
6. Dean M., Hamon Y., and Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J. Lipid Res. 42 (2001) 1007-1017
7. Diestel A., Aktas O., Hackel D., Hake I., Meier S., Raine C.S., Nitsch R., Zipp F., and Ullrich O. Activation of microglial Poly(ADP-ribose)-Polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J. Exp. Med. 198 11 (2003) 1729-1740
8. Hemmer B., Cepok S., Nessler S., and Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr. Opin. Neurol. 15 3 (2002) 227-231
9. Joseph S.B., Castrillo A., Lafitte B.A., Mangelsdorf D.J., and Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 2 (2003) 213-219
10. Joseph S.B., Bradley M.N., Castrillo A., Bruhn K.W., Mak P.A., Pei L., Hogenesch J., O'connell R.M., Cheng G., Saez E., Miller J.F., and Tontonoz P. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119 2 (2004) 299-309
11. Leoni V., Masterman T., Diczfalusy U., De Luca G., Hillert J., and Bjorkem I. Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycolesterol during progression of multiple sclerosis. Neurosci. Lett. 33 (2002) 163-167
12. Mac Donald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 1 (2001) 121-127
13. Morra V.B., Coppola G., Orefice G., De Michele G., Vacca G., Filla A., and Bonavita V. Interferon-β treatment decreases cholesterol plasma levels in multiple sclerosis patients. Neurology 62 (2004) 829-830
14. Neuhaus G., Strasser-Fuchs S., Fazekas F., Kieseier B.C., Niederwieser G., Hartung H.P., and Archelos J.J. Statins as immunomodulators. Comparison with interferon 1b in MS. Neurology 59 (2002) 990-997
15. Paintlia A.S., Paintlia M.K., Singh A.K., Stanislaus R., Gilg A.G., Barbosa E., and Singh I. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin. J. Neurosci. Res. 77 1 (2004) 63-81
16. Sun Y., Yao J., Kim T.W., and Tall A.R. Expression of liver X receptor target genes decreases cellular amyloid β peptide secretion. J. Biol. Chem. 278 30 (2003) 27688-27694
17. Teunnissen C.E., Dijkstra C.D., Polman C.H., Hoogervorst E.L., von Bergmann K., and Lutjohann D. Decreased levels of the brain specific 24S-hydroxycolesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci. Lett. 347 3 (2003) 159-162
18. Valledor A.F., Hsu L.C., Ogawa S., Sawka-Verhelle D., Karin M., and Glass C.K. Activation of liver X receptors and retinoid receptors prevents bacterial-induced macrophage apoptosis. PNAS 101 51 (2004) 17813-17818
19. Venkateswaran A., Repa J.J., Lobaccaro J.M., Bronson A., Mangelsdorf D.J., and Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275 19 (2000) 14700-14707
20. Walcher D., Kummel A., Keherie B., Bach H., Grub M., Durst R., Hombach V., and Marx N. LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler. Thromb. Vasc. Biol. 26 5 (2006) 1022-1028
21. Wang L., Schuster G.U., Hultenby K., Zhang Q., Andersson S., and Gustafsson J. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. PNAS 99 21 (2002) 13878-13883
22. Weber M.S., Youssef S., Dunn S.E., Prod'homme T., Neuhaus O., Stuve O., Greenwood J., Steinman L., and Zamvil S.S. Statins in treatment of central nervous system autoimmune disease. J. Neuroimmunol. 178 1-2 (2006) 140-148
23. Wong J., Quinn C.M., and Brown A.J. Statins inhibit synthesis of an oxysterol ligand for the liver X receptor in human macrophages with consequences for cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 24 12 (2004) 2365-2371
24. Wong J., Quinn C.M., and Brown A.J. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J. 400 3 (2006) 485-491